Journals / Genel Tıp Dergisi / 2005 / Cilt: 15 - Sayı: 1

Etiopathogenesis, diagnosis and management in rosacea

Rozaseada etyopatogenez, tanı ve tedavi

Pages
35–41
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Same difficulty lasts during the treatment and because of this, treatment requires multidisciplinary and combined approaches.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Objective: In this review, clinic types of rosasea, etiopathogenesis, diagnosis, differential diagnosis and treatment methods have been mentioned and updated information on this disease has been compiled.
📊
Key Findings & Data:Main findings: One of the most inflammatory skin diseases is rosacea and most of the symptoms of disease begin between the ages of 30-60.
💡
Conclusion & Impact:Same difficulty lasts during the treatment and because of this, treatment requires multidisciplinary and combined approaches.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Tanı · Tanı · ayırıcı

Abstract

Objective: In this review, clinic types of rosasea, etiopathogenesis, diagnosis, differential diagnosis and treatment methods have been mentioned and updated information on this disease has been compiled. Main findings: One of the most inflammatory skin diseases is rosacea and most of the symptoms of disease begin between the ages of 30-60. It is a chronic disease, characterized by exacerbations and remissions and affects mostly women. With sixth decades, it has been observed in 1.2-5.4% of the population. In clinic presentations, together with cutaneous symptoms like flushing, erythema, edema, telangiectasia, papules, pustules and rhinophyma, various ocular symptoms can be found in different ratios. For the topical treatment, mostly azelaic acid and metronidazole are used. Systematically, at the beginning, tetracyclines and then some various antibiotics and isotretinoin are preferred. For the treatment of telangiectasia, erythema and rhinophyma, some lasers can be used. Conclusion: Since many other diseases have similar symptoms to rosasea, it becomes hard to diagnose for the disease. Same difficulty lasts during the treatment and because of this, treatment requires multidisciplinary and combined approaches.

Özet

Amaç: Bu makalede rozaseanın etyopatogenezi, klinik tipleri, tanı, ayırıcı tanı ve tedavisi üzerinde durularak güncel bilgiler derlenmiştir. Ana bulgular: Rozasea, sık görülen inflamatuvar deri hastalıklarından biridir ve hastalığın semptomları en sık 30-60 yaşları arasında başlamaktadır. Kronik, alevlenme ve iyilik halleri ile sürmekte ve daha çok kadınları etkilemektedir. Altıncı dekatla beraber % 1.2-5.4 oranında görüldüğü bildirilmektedir. Kliniğinde flaşing, eritem, ödem, telenjiektazi, papül, püstül ve rinofima gibi kutanöz bulguların yanı sıra çeşitli oküler bulgular farklı oran ve şiddetlerde gözlenmektedir. Hastalığın tedavisinde topikal olarak en çok azelaik asit ve metronidazol kullanılmaktadır. Sistemik olarak başta tetrasiklinler olmak üzere çeşitli antibiyotikler ve isotretinoin tercih edilmektedir. Telenjiektazi, eritem ve rinofima tedavisinde ise çeşitli lazerler kullanılabilmektedir. Sonuç: Rozaseanın ayırıcı tanısına pek çok hastalık girmekte ve tanıda güçlüğe neden olabilmektedir. Aynı zorluk tedavide de sürmekte, multidisipliner ve kombine tedavi yaklaşımlarını gerektirmektedir.

🔖

Cite This Article

ARICAN, Ö. (2005). Etiopathogenesis, diagnosis and management in rosacea. Genel Tıp Dergisi, Cilt: 15 - Sayı: 1, 35–41. https://ajindex.com/articles/224938

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (18)

  1. Webster GF. Rosacea and related disorders. İçinde: Bolognia JL, Jorizzo JL, Rapini RP, et al (editörler), Dermatology, Vol:I, 1st ed. Mosby, USA, 2003, p:545-52
  2. Plewing G, Jansen T. Rosacea. İçinde: Freedberg IM, Eisen AZ, Wolff K, Austen KF, Goldsmith LA, Katz SI (editörler). Fitzpatrick’s Dermatology in General Medicine, Vol: I, 6th ed. McGraw-Hill Inc, USA, 2003, p:688-96
  3. Zuber TJ. Rosacea. Dermatology 2000;27:309-18
  4. Litt JZ. Rosacea: How to recognize and treat an age-related skin disease. Geriatrics 1997;52:39-47
  5. Öztaş MO, Balk M, Öğüş E, Bozkurt M, Öğüş IH, Özer N. The role of free oxygen radicals in the aetiopathogenesis of rosacea. Clin Exp Dermatol 2003;28:188-92
  6. Berg M, Liden S. An epidemiological study of rosacea. Acta Derm Venereol 1989;69:419-23
  7. Wilkin J, Dahl M, Detmar M, Drake L, Feinstein A, Odom R, Powel F. Standart classification of rosacea: Report of the National Rosacea Society Expert Committee on the Classification and Staging of rosacea. J Am Acad Dermatol 2002;46:584-7
  8. Hirsch RJ, Weinberg JM. Rosacea 2000. Cutis 2000;66:125-8
  9. Braun-Falco O, Plewing G, Wolff HH, Burgdorf WHC. Diseases of sebaceous glands. İçinde: Dermatology, 2nd ed. Springer-Verlag, Berlin, 2000, p:1051-81
  10. Cohen A, Tiemstra J. Diagnosis and treatment of rosacea. J Am Board Fam Pract 2002;15:214-7
  11. Neumann E, Frithz A. Capillaropathy and capillaroneogenesis in the pathogenesis of rosacea. Int J Dermatol 1998;37:263-6
  12. Thomas J, Plewig G. Rosacea: classification and treatment. J Royal Soc Med 1997;90:144-50
  13. Şahin S, Özdamar Ş, Seçkin D, Ekşioğlu M, Yavuz İ, Turanlı AY, ve ark. Rozaseada vazoaktif intestinal polipeptid immünreaktivitesi ve mast hücreleri. Turk J Dermatopathol 1995;1-2:41-4
  14. Rebora A, Drago F, Parodi A. May Helicobacter pylori be important for dermatologist? Dermatology 1995;191:6-8
  15. Abrahamovyhch LI. The clinical and morphofunctional status of the esophagogastroduodenal system in patients with acne rosacea: etiological, pathogenic, and therapeutic aspects. Lik Sprava 1996;10-12:84-8
  16. Gürer MA, Erel A, Erbaş D, Çağlar K, Atahan Ç. The seroprevalence of Helicobacter pylori and nitric oxide in acne rosacea. Int J Dermatol 2002;41:768-70
  17. Şavk E, Karaoğlu AÖ, Karaman G, Şendur N. Rozasea-Helikobakter pylori-Üst GİS patolojisi; endoskopik değerlendirme. T Klin Dermatol 2001;11:121-5
  18. Sharma VK, Lynn A, Kaminski M, Vasudeva R, Howden CW. A study of the prevalence of Helicobacter pylori in